Biovica Biovica is a biotech company that develops and commercializes blood-based biomarker assays that help to monitor cancer therapies and predict patient outcomes. | ![]() Biocept Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer. | |
Founding Date | Founding Date 2009 | Founding Date 1993 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Uppsala, SE HQ Waltham, US | Locations San Diego, US HQ |
Employees | Employees 26 | Employees 878% decrease |
Valuation ($) | Valuation ($) 20.5 m | Valuation ($) N/A |
Financial | ||
Revenue (est.) | Revenue (est.) kr13.4m (FY, 2026) | Revenue (est.) $25.9m (FY, 2022) |
Cost of goods | Cost of goods kr43k (FY, 2026) | Cost of goods $28.4m (FY, 2022) |
Gross profit | Gross profit kr14m (FY, 2026) | Gross profit ($2.5m) (FY, 2022) |
Net income | Net income (kr69.9m) (FY, 2026) | Net income ($32.1m) (FY, 2022) |

Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer.
View company